Findings

What do systematic reviews say?

2 questions · 3 findings · 3 reviews

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 1 · 33.3%High 0 · 0%

All‐cause mortality

It is very uncertain whether insulin analogues changes all‐cause mortality compared with biphasic insulin (very low certainty).

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
RR 3.02 [0.12, 73.53]
1 study · 263 participants
Very low

All‐cause mortality

Short‐acting insulin analogues showed no clear difference in all‐cause mortality (N) compared with regular human insulin (moderate certainty).

2 findings from 2 reviews · compare the 2 reviews